Erika Hamilton, MD, director of Breast Cancer Research at the Sarah Cannon Research Institute, discusses some of the emerging ...

BC, and Sandra Sepulveda, AGPNP-BC, MSN, BMTCN, discussed what went into developing this Malignant Hematology and Bone Marrow ...

Aumolertinib improved progression-free survival vs placebo in patients with unresectable stage III non–small cell lung cancer ...

During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed CAR T-cell therapy as third-line therapy for ...

Noah S. Kalman, MD, MBA, discusses the most common types of thyroid cancer and their respective prognosis.

Jacob Stein, MD, MPH, discusses how nab-sirolimus improves outcomes for patients with advanced perivascular epithelioid cell tumors compared with other treatments or no treatment options.